collection
https://read.qxmd.com/read/35191944/hypernatremia
#1
JOURNAL ARTICLE
Kamel S Kamel, Martin Schreiber, Ziv Harel
No abstract text is available yet for this article.
February 22, 2022: JAMA
https://read.qxmd.com/read/35257065/acute-kidney-disease-after-acute-decompensated-heart-failure
#2
JOURNAL ARTICLE
Jia-Jin Chen, Tao-Han Lee, George Kuo, Chieh-Li Yen, Shao-Wei Chen, Pao-Hsien Chu, Pei-Chun Fan, Victor Chien-Chia Wu, Chih-Hsiang Chang
INTRODUCTION: Acute kidney disease (AKD) represents a continuum of kidney injury for 7 to 90 days after acute kidney injury (AKI). The incidence and prognosis of AKD after acute decompensated heart failure (ADHF) are currently unclear. The aims of this study were to explore the incidence of AKD and the transition from AKI to AKD, to identify risk factors for AKD and develop a prediction model for any-stage AKD, and to evaluate the prognosis of AKD. METHODS: A total of 7519 patients admitted for ADHF between January 1, 2008, and December 31, 2018, from a multi-institutional database were identified...
March 2022: KI Reports
https://read.qxmd.com/read/35268545/rethinking-resistant-hypertension
#3
REVIEW
Gabrielle Bourque, Swapnil Hiremath
Resistant hypertension is common and known to be a risk factor for cardiovascular events, including stroke, myocardial infarction, heart failure, and cardiovascular mortality, as well as adverse renal events, including chronic kidney disease and end-stage kidney disease. This review will discuss the definition of resistant hypertension as well as the most recent evidence regarding its diagnosis, evaluation, and management. The issue of medication non-adherence and its association with apparent treatment-resistant hypertension will be addressed...
March 7, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/35273009/drug-induced-acute-kidney-injury
#4
REVIEW
Mark A Perazella, Mitchell H Rosner
Medications are a common cause of AKI, especially for patients admitted to hospital wards and the intensive care unit. Although drug-related kidney injury occurs through different mechanisms, this review will focus on three specific types of tubulointerstitial injury. Direct acute tubular injury develops from several medications, which are toxic to various cellular functions. Their excretory pathways through the proximal tubules contribute further to AKI. Drug-induced AKI may also develop through induction of inflammation within the tubulointerstitium...
August 2022: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/35311788/early-vasopressor-initiation-increases-mortality-in-patients-with-septic-shock-less-intensive-intervention-or-more-critically-ill-patients
#5
LETTER
Heyan Wang, Hangyong He, Feng Shen
No abstract text is available yet for this article.
April 1, 2022: Critical Care Medicine
https://read.qxmd.com/read/34213593/acute-kidney-injury-in-the-critically-ill-an-updated-review-on-pathophysiology-and-management
#6
REVIEW
Peter Pickkers, Michael Darmon, Eric Hoste, Michael Joannidis, Matthieu Legrand, Marlies Ostermann, John R Prowle, Antoine Schneider, Miet Schetz
Acute kidney injury (AKI) is now recognized as a heterogeneous syndrome that not only affects acute morbidity and mortality, but also a patient's long-term prognosis. In this narrative review, an update on various aspects of AKI in critically ill patients will be provided. Focus will be on prediction and early detection of AKI (e.g., the role of biomarkers to identify high-risk patients and the use of machine learning to predict AKI), aspects of pathophysiology and progress in the recognition of different phenotypes of AKI, as well as an update on nephrotoxicity and organ cross-talk...
July 2, 2021: Intensive Care Medicine
https://read.qxmd.com/read/34247883/iga-nephropathy-core-curriculum-2021
#7
REVIEW
Prapa Pattrapornpisut, Carmen Avila-Casado, Heather N Reich
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease worldwide. The diagnostic histologic hallmark is dominant or codominant IgA staining on kidney biopsy; however, patients may present with various clinical syndromes ranging from asymptomatic abnormalities noted on urinalysis to rapidly progressive glomerulonephritis. Given substantial heterogeneity in the clinical course of disease, online risk calculators are available that may assist in prognostication and inform discussions with patients...
September 2021: American Journal of Kidney Diseases
https://read.qxmd.com/read/33246294/pulmonary-pathology-of-ards-in-covid-19-a-pathological-review-for-clinicians
#8
REVIEW
Sabrina Setembre Batah, Alexandre Todorovic Fabro
COVID-19 has quickly reached pandemic levels since it was first reported in December 2019. The virus responsible for the disease, named SARS-CoV-2, is enveloped positive-stranded RNA viruses. During its replication in the cytoplasm of host cells, the viral genome is transcribed into proteins, such as the structural protein spike domain S1, which is responsible for binding to the cell receptor of the host cells. Infected patients have initially flu-like symptoms, rapidly evolving to severe acute lung injury, known as acute respiratory distress syndrome (ARDS)...
January 2021: Respiratory Medicine
https://read.qxmd.com/read/33229333/advances-in-the-diagnosis-and-management-of-gastroesophageal-reflux-disease
#9
REVIEW
David A Katzka, Peter J Kahrilas
Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart morbidity, mainly through troublesome symptoms. Major GERD phenotypes are non-erosive reflux disease, GERD hypersensitivity, low or high grade esophagitis, Barrett's esophagus, reflux chest pain, laryngopharyngeal reflux, and regurgitation dominant reflux. GERD is common throughout the world, and its epidemiology is linked to the Western lifestyle, obesity, and the demise of Helicobacter pylori...
November 23, 2020: BMJ: British Medical Journal
https://read.qxmd.com/read/33184265/delirium
#10
REVIEW
Jo Ellen Wilson, Matthew F Mart, Colm Cunningham, Yahya Shehabi, Timothy D Girard, Alasdair M J MacLullich, Arjen J C Slooter, E Wesley Ely
Delirium, a syndrome characterized by an acute change in attention, awareness and cognition, is caused by a medical condition that cannot be better explained by a pre-existing neurocognitive disorder. Multiple predisposing factors (for example, pre-existing cognitive impairment) and precipitating factors (for example, urinary tract infection) for delirium have been described, with most patients having both types. Because multiple factors are implicated in the aetiology of delirium, there are likely several neurobiological processes that contribute to delirium pathogenesis, including neuroinflammation, brain vascular dysfunction, altered brain metabolism, neurotransmitter imbalance and impaired neuronal network connectivity...
November 12, 2020: Nature Reviews. Disease Primers
https://read.qxmd.com/read/33160639/clinical-management-of-hyperkalemia
#11
REVIEW
Biff F Palmer, Juan Jesus Carrero, Deborah J Clegg, Gates B Colbert, Michael Emmett, Steven Fishbane, Debra J Hain, Edgar Lerma, Macaulay Onuigbo, Anjay Rastogi, Simon D Roger, Bruce S Spinowitz, Matthew R Weir
Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences. Despite various guidelines, no universally accepted consensus exists on best practices for hyperkalemia monitoring, with variations in precise potassium (K+ ) concentration thresholds or for the management of acute or chronic hyperkalemia. Based on the available evidence, this review identifies several critical issues and unmet needs with regard to the management of hyperkalemia. Real-world studies are needed for a better understanding of the prevalence of hyperkalemia outside the clinical trial setting...
November 4, 2020: Mayo Clinic Proceedings
https://read.qxmd.com/read/32613148/mechanisms-of-cardiovascular-benefits-of-sodium-glucose-co-transporter-2-sglt2-inhibitors-a-state-of-the-art-review
#12
REVIEW
Gary D Lopaschuk, Subodh Verma
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have dramatic beneficial cardiovascular outcomes. These include a reduced incidence of cardiovascular death and heart failure hospitalization in people with and without diabetes, and those with and without prevalent heart failure. The actual mechanism(s) responsible for these beneficial effects are not completely clear. Several potential theses have been proposed to explain the cardioprotective effects of SGLT2 inhibition, which include diuresis/natriuresis, blood pressure reduction, erythropoiesis, improved cardiac energy metabolism, inflammation reduction, inhibition of the sympathetic nervous system, prevention of adverse cardiac remodeling, prevention of ischemia/reperfusion injury, inhibition of the Na+ /H+ -exchanger, inhibition of SGLT1, reduction in hyperuricemia, increasing autophagy and lysosomal degradation, decreasing epicardial fat mass, increasing erythropoietin levels, increasing circulating pro-vascular progenitor cells, decreasing oxidative stress, and improving vascular function...
June 2020: JACC. Basic to Translational Science
https://read.qxmd.com/read/32940785/causes-and-management-of-non-cirrhotic-portal-hypertension%C3%A2
#13
REVIEW
Stefania Gioia, Silvia Nardelli, Lorenzo Ridola, Oliviero Riggio
PURPOSE OF THE REVIEW: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. The aim of this paper is to make an overview on the denominations, diagnostical features and management of porto-sinusoidal vascular disease (PSVD) and chronic portal vein thrombosis (PVT) being the main causes of NCPH in the Western world. RECENT FINDINGS: The management of NCPH consists in the treatment of associated diseases and of portal hypertension (PH)...
September 17, 2020: Current Gastroenterology Reports
https://read.qxmd.com/read/32699026/respiratory-viral-sepsis-epidemiology-pathophysiology-diagnosis-and-treatment
#14
REVIEW
Xiaoying Gu, Fei Zhou, Yeming Wang, Guohui Fan, Bin Cao
According to the Third International Consensus Definition for Sepsis and Septic Shock, sepsis is a life-threatening organ dysfunction resulting from dysregulated host responses to infection. Epidemiological data about sepsis from the 2017 Global Burden of Diseases, Injuries and Risk Factor Study showed that the global burden of sepsis was greater than previously estimated. Bacteria have been shown to be the predominant pathogen of sepsis among patients with pathogens detected, while sepsis caused by viruses is underdiagnosed worldwide...
September 30, 2020: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/32940635/change-in-antibodies-to-sars-cov-2-over-60-days-among-health-care-personnel-in-nashville-tennessee
#15
JOURNAL ARTICLE
Manish M Patel, Natalie J Thornburg, William B Stubblefield, H Keipp Talbot, Melissa M Coughlin, Leora R Feldstein, Wesley H Self
This study examines the duration of antibody response to SARS-CoV-2 in health care personnel over a 60-day period in Nashville, Tennessee.
November 3, 2020: JAMA
https://read.qxmd.com/read/32780104/managing-electrolyte-disorders-order-a-basic-urine-metabolic-panel
#16
EDITORIAL
Richard H Sterns
No abstract text is available yet for this article.
November 1, 2020: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/32749493/heart-failure-with-reduced-ejection-fraction-a-review
#17
REVIEW
Sean P Murphy, Nasrien E Ibrahim, James L Januzzi
IMPORTANCE: Worldwide, the burden of heart failure has increased to an estimated 23 million people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF). OBSERVATIONS: Heart failure is a clinical syndrome characterized by dyspnea or exertional limitation due to impairment of ventricular filling or ejection of blood or both. HFrEF occurs when the left ventricular ejection fraction (LVEF) is 40% or less and is accompanied by progressive left ventricular dilatation and adverse cardiac remodeling...
August 4, 2020: JAMA
https://read.qxmd.com/read/32663831/etiology-and-management-of-acute-metabolic-acidosis-an-update
#18
JOURNAL ARTICLE
Igor Matyukhin, Susann Patschan, Oliver Ritter, Daniel Patschan
BACKGROUND: The etiology of acute metabolic acidosis (aMA) is heterogeneous, and the consequences are potentially life-threatening. The aim of this article was to summarize the causes and management of aMA from a clinician's perspective. SUMMARY: We performed a systematic search on PubMed, applying the following search terms: "acute metabolic acidosis," "lactic acidosis," "metformin" AND "acidosis," "unbalanced solutions" AND "acidosis," "bicarbonate" AND "acidosis" AND "outcome," "acute metabolic acidosis" AND "management," and "acute metabolic acidosis" AND "renal replacement therapy (RRT)/dialysis...
2020: Kidney & Blood Pressure Research
https://read.qxmd.com/read/32682486/temporary-circulatory-support-for-cardiogenic-shock
#19
REVIEW
Alain Combes, Susanna Price, Arthur S Slutsky, Daniel Brodie
Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or from progression of long-standing underlying heart disease. When addressing the cause of underlying disease, the management of cardiogenic shock consists of vasopressors and inotropes; however, these agents can increase myocardial oxygen consumption, impair tissue perfusion, and are frequently ineffective. An alternative approach is to temporarily augment cardiac output using mechanical devices. The use of these devices-known as temporary circulatory support systems-has increased substantially in recent years, despite being expensive, resource intensive, associated with major complications, and lacking high-quality evidence to support their use...
July 18, 2020: Lancet
https://read.qxmd.com/read/32600375/update-of-the-treatment-of-nosocomial-pneumonia-in-the-icu
#20
REVIEW
Rafael Zaragoza, Pablo Vidal-Cortés, Gerardo Aguilar, Marcio Borges, Emili Diaz, Ricard Ferrer, Emilio Maseda, Mercedes Nieto, Francisco Xavier Nuvials, Paula Ramirez, Alejandro Rodriguez, Cruz Soriano, Javier Veganzones, Ignacio Martín-Loeches
In accordance with the recommendations of, amongst others, the Surviving Sepsis Campaign and the recently published European treatment guidelines for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), in the event of a patient with such infections, empirical antibiotic treatment must be appropriate and administered as early as possible. The aim of this manuscript is to update treatment protocols by reviewing recently published studies on the treatment of nosocomial pneumonia in the critically ill patients that require invasive respiratory support and patients with HAP from hospital wards that require invasive mechanical ventilation...
June 29, 2020: Critical Care: the Official Journal of the Critical Care Forum
label_collection
label_collection
6529
1
2
2020-07-26 20:06:44
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.